Skip to main content
Rates starting at

$XXX USD

Select your dates at Cambria Hotel Boston, Downtown-South Boston

Your Selected Dates 1 night

  • Thursday
  • 1 night
  • Sunday
Submit dates

Reservation: 617-752-6681

Check-in: 3:00 PM Check-out: 11:00 AM

Pets allowed: No

Book Direct Benefits
  • Members Save 7%
  • Lowest price guaranteed
  • Earn Choice Privileges points on your stay

3rd RAS/MAPK Pathway Targeted Drug Discovery Summit

Other
February 22, 2022 to February 24, 2022
9:00 AM - 3:30 PM
Hyatt Regency Boston, 1 Avenue de Lafayette,, Suffolk County, Massachusetts, United States, 02111

About This Event

For decades, RAS proteins have been considered “undruggable.” This all changed following the recent approval of the first-ever targeted KRAS G12C therapy, marking a major landmark for this community. This breakthrough has certainly laid out a roadmap for future success, with more investment and innovation in the field than ever before, particularly within emerging discovery strategies being pursued by the biopharma industry.\ \ Along with this success, significant efforts are now being placed within discovery of drugs that treat a broader range of RAS mutants beyond G12C. The 3rd RAS/MAPK Pathway Targeted Drug Discovery Summit, will shine a spotlight onto pioneering discovery effort targeting the RAS/MAPK pathway, and benchmark the various innovative modalities being harnessed to target RAS mutations beyond G12C, giving you the opportunity to establish and accelerate your drug discovery platform by targeting the RAS/MAPK pathway at every turn.